![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Shire M.G. Muller G.W.
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.8, Iss.5, 1998-05, pp. : 531-544
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
How should TNF inhibitors be used in rheumatoid arthritis?
Inpharma, Vol. 1, Iss. 1250, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-TNF Treatment in Rheumatoid Arthritis
Current Pharmaceutical Design, Vol. 17, Iss. 29, 2011-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
TNF inhibition as therapy for rheumatoid arthritis
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 7, 2002-07 ,pp. :